Bipolarity
Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.
CompletedNCT00545675
Official study titleMulti-center, Double-blind, Randomized, Comparative Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of Abilify and Depakote in 24-week Treatment of Mania in Patients With Bipolar Disorder Remitted After 6-week Treatment With Abilify and Depakote
This study has finished and is no longer accepting participants.
In SeoulBipolarityMedication studyAges 18–65
- Countries
- South Korea
- Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
CompletedNCT00545142
Official study titleMulti-center, Single Arm, Open Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of Abilify With Depakote in the 6-week Treatment of Acute Mania in Patients With Bipolar Disorder
This study has finished and is no longer accepting participants.
In SeoulBipolarityMedication studyAges 18–65
- Countries
- South Korea
- Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
CompletedNCT00106405
Official study titleA Pilot Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including National CityBipolarityMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Forest Laboratories
CompletedNCT00060905
Official study titleAn Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including CerritosBipolarityMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Abbott
CompletedNCT00067262
Official study titleA Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Depakote ER for the Treatment of Bipolar Disorder in Children and Adolescents
This study has finished and is no longer accepting participants.
Multiple locations, including StanfordBipolarityMedication studyAges 10–17
- Countries
- United States
- Sponsor
- Abbott
TerminatedNCT00063362
Official study titleCombination Therapy in Bipolar Rapid Cycling
This study ended early.
Location not clearly listedBipolarityMedication studyAges 16+
- Countries
- Sponsor
- University Hospitals Cleveland Medical Center
CompletedNCT03857438
Official study titleCorrelation of Audiovisual Features With Clinical Variables and Neurocognitive Functions in Bipolar Disorder, Mania
This study has finished and is no longer accepting participants.
In IstanbulBipolarityObservational studyAges 18–65
- Countries
- Türkiye
- Sponsor
- Istanbul Saglik Bilimleri University
CompletedNCT04696471
Official study titleElucidating Neural Mechanisms of Hypo/Mania Using Theta Burst Stimulation
This study has finished and is no longer accepting participants.
In PittsburghBipolarityDevice studyAges 18–35
- Countries
- United States
- Sponsor
- Mary Phillips, MD MD (Cantab)
TerminatedNCT01824602
What is this study about?Researchers are comparing Eslicarbazepine acetate 1800 mg, Eslicarbazepine acetate 1200 mg, Eslicarbazepine acetate 600 mg and placebo to find out how the approaches affect manic symptoms in people with bipolarity type I during a manic episode.
This study ended early.
Location not clearly listedBipolarityMedication studyAges 18+
- Countries
- Sponsor
- Bial - Portela C S.A.
CompletedNCT01822678
What is this study about?Researchers compared Eslicarbazepine Acetate and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I during a manic episode.
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityMedication studyAges 18+
- Countries
- Sponsor
- Bial - Portela C S.A.
CompletedNCT00195767
Official study titleAn Open-Label Long-Term Study to Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents
This study has finished and is no longer accepting participants.
In North ChicagoBipolarityMedication studyAges 10–17
- Countries
- United States
- Sponsor
- Abbott
CompletedNCT00571402
Official study titleFamily-Focused Psychoeducation for Bipolar Adolescents
This study has finished and is no longer accepting participants.
Multiple locations, including BoulderBipolarityBehavioural studyAges 12–17
- Countries
- United States
- Sponsor
- University of California, Los Angeles